相关实验视频

Updated: Jan 18, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

缺氧通过通过TRIM21抑制稳定ID1促进胰腺腺癌的进展

Rui Cheng^1,2, Yuanjun Tang^2,3, Xuedi Cao^2,3

¹Peking University Third Hospital Cancer Center, Department of Radiation Oncology, Peking University Third Hospital, Beijing, China.

Frontiers in oncology

|September 8, 2025

概括

缺氧通过减少TRIM21,促进瘤生长来稳定胰腺癌中的瘤性ID1. 恢复TRIM21介导的ID1降解为胰腺腺癌 (PAAD) 提供了潜在的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

胰腺腺癌 (PAAD) 是具有侵略性的,低氧促进进展和治疗抵抗.
瘤调节剂ID1与PAAD有关,但缺氧诱导的稳定机制和无素介导的降解作用尚不清楚.

研究的目的:

阐明PAAD中缺氧诱导的ID1稳定机制.
为了研究在ID1调节中受乌比奎丁介导的降解作用.
通过了解ID1通路来确定PAAD的新型治疗点.

主要方法:

在低氧条件下的PAAD组织和细胞系中检查ID1表达.
通过循环赫西米德追逐和抑制试验评估蛋白质稳定性.
通过质谱测量确定TRIM21为一种与ID1相互作用的E3泛基因酶.
评估了ID1和TRIM21在瘤生长中的作用,使用体内异种移植.

主要成果:

在PAAD中,ID1过度表达,与晚期和低生存率相关.
缺氧增加了ID1蛋白水平,通过通过TRIM21下调来抑制其无素蛋白酶降解.
在TRIM21中,Knockdown增加了ID1和瘤细胞功能;TRIM21过度表达抑制了恶性瘤.
沉默ID1阻碍了瘤的生长,而TRIM21倒置在体内加速了瘤的生长.

结论:

缺氧通过降低TRIM21的调节,稳定ID1.1,推动PAAD的进展.
TRIM21-ID1轴是PAAD的一个有前途的治疗点.
恢复TRIM21介导的ID1降解可能会抵消缺氧诱导的胰腺癌恶性.

关键词:

Id1 Id1 的意思是在 TRIM2121 中.缺氧缺氧是指缺氧的情况.胰腺腺癌的癌症.无处不在的化

更多相关视频

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...